Development of an mRNA replacement therapy for phenylketonuria
Phenylketonuria (PKU) is an inborn error caused by deficiencies in phenylalanine (Phe) metabolism. Mutations in the phenylalanine hydroxylase (PAH) gene are the main cause of the disease whose signature hallmarks of toxically elevated levels of Phe accumulation in plasma and organs such as the brain...
| Published in: | Molecular Therapy: Nucleic Acids |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-06-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253122000488 |
